Bioskin GmbH
10
1
1
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
10%
1 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Role: collaborator
Study to Evaluate Efficacy and Safety of MP1032 in Patients With Chronic Plaque Psoriasis
Role: collaborator
Evaluation of Efficacy and Safety of Oral Minoxidil 1 mg in Female Androgenetic Alopecia
Role: collaborator
KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC)
Role: collaborator
Assessment of Wound Healing, Cooling Efficacy and Local Tolerability of a Wound Care Hydrogel
Role: collaborator
Efficacy and Safety of Novel Formulations of Topical Calcipotriol in Patients With Mild to Moderate Plaque Psoriasis
Role: collaborator
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
Role: collaborator
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
Role: collaborator
Antipsoriatic Effect of a Topical Formulation for the Treatment of Psoriasis Vulgaris
Role: collaborator
Study of CRx-191 to Assess Activity in Plaque Psoriasis
Role: collaborator
All 10 trials loaded